¶óÆæÆ®¦¢Ä«Æä¦¢ºí·Î±×¦¢´õº¸±â
¾ÆÄ«µ¥¹Ì Ȩ ¸í»çƯ°­ ´ëÇבּ¸½Ç޹æ Á¶°æ½Ç¹« µ¿¿µ»ó°­ÀÇ Çѱ¹ÀÇ ÀüÅëÁ¤¿ø ÇÐȸº° ³í¹®
ÇÐȸº° ³í¹®

Çѱ¹°Ç¼³°ü¸®ÇÐȸ
Çѱ¹°ÇÃà½Ã°øÇÐȸ
Çѱ¹µµ·ÎÇÐȸ
Çѱ¹»ý¹°È¯°æÁ¶ÀýÇÐȸ
Çѱ¹»ýÅÂÇÐȸ
Çѱ¹¼öÀÚ¿øÇÐȸ
Çѱ¹½Ä¹°ÇÐȸ
Çѱ¹½Ç³»µðÀÚÀÎÇÐȸ
Çѱ¹ÀÚ¿ø½Ä¹°ÇÐȸ
Çѱ¹ÀܵðÇÐȸ
Çѱ¹Á¶°æÇÐȸ
Çѱ¹Áö¹Ý°øÇÐȸ
Çѱ¹ÇÏõȣ¼öÇÐȸ
Çѱ¹È¯°æ»ý¹°ÇÐȸ
Çѱ¹È¯°æ»ýÅÂÇÐȸ

Çѱ¹È¯°æ»ý¹°ÇÐȸ / v.21, no.2, 2003³â, pp.87-100
ÇÁ·ÎÅ׿À¹Í½º¸¦ ÀÌ¿ëÇÑ ³»ºÐºñ°è ±³¶õ¹°Áú ȯ°æµ¶¼º ¿¬±¸
( Proteome in Toxicological Assessment of Endocrine Disrupting Chemicals )
±èÈ£½Â;°è¸íÂù; ÇѾç´ëÇб³ ÀÚ¿¬°úÇдëÇÐ »ý¸í°úÇаú;ÇѾç´ëÇб³ ÀÚ¿¬°úÇдëÇÐ »ý¸í°úÇаú;
 
ÃÊ ·Ï
ȯ°æ¿À¿°ÀÌ ½É°¢ÇØÁü¿¡ µû¶ó ±¹³»¿ÜÀûÀ¸·Î ȯ°æ¿¡ ´ëÇÑ °ü½ÉÀÌ °íÁ¶µÇ°í ÀÎü¿¡ ÇØ¸¦ ³¢Ä¡´Â ȯ°æ¿äÀÎÀ¸·ÎºÎÅÍ ¹æ¾îÇϱâ À§ÇÑ ¸¹Àº ³ë·ÂµéÀÌ ±â¿ï¿©Áö°í ÀÖ´Ù. ƯÈ÷ ³»ºÐºñ°èÀå¾Ö¹°ÁúÀÌ »ý½Ä±â´É°ú ¸é¿ª±â´ÉÀ» ¾àÈ­½Ã۰í, Çൿ ÀÌ»óÀ» ÀÏÀ¸Å°¸ç, ¾Ï ¹ß»ý·üÀ» ³ôÀδٴ Á¡ÀÌ ¹àÇôÁö±â ½ÃÀÛÇϸ鼭 ¸¹Àº ¿¬±¸µéÀÌ ¹ßÇ¥µÇ°í ¿©·¯ °¡Áö ¹æ¹ýµéÀÌ ³»ºÐºñ°èÀå¾Ö¹°Áú°ú ´õºÒ¾î ȯ°æºÐ¾ß¿¬±¸¿¡ ÀÀ¿ëµÇ¾î¿ÔÁö¸¸ ´Ü¹éÁúÀ» ´ë»óÀ¸·Î ¿¬±¸ÇÏ¿© À¯ÀüÀÚ±â´ÉÀ» ¿¬±¸ÇÏ´Â ÇÁ·ÎÅ׿À¹Í½º(proteomics) ¿¬±¸¸¦ Á¢¸ñ½ÃŰ·Á´Â ½Ãµµ°¡ ¾ÆÁ÷±îÁö´Â ºó¾àÇÏ´Ù. ÇÁ·ÎÅ׿À¹Í½º´Â ±â´ÉÀ» °®´Â ´Ü¹éÁúµéÀÇ ¹ßÇöÀ» Á¾ÇÕÀûÀ̰í Á¤·®ÀûÀ¸·Î ÃøÁ¤ÇÏ´Â °¡Àå Á÷Á¢ÀûÀÎ ¼ö´ÜÀ̰í, Áúº´, ¾à¹°Åõ¿©, shock µî »ý¹°ÇÐÀûÀÎ µ¿¿ä(perturbation)¿¡ ÀÇÇÏ¿© º¯ÇÏ´Â ´Ü¹éÁúµéÀÇ ¹ßÇö¾ç»óÀÇ º¯È­¸¦ Á¤È®ÇÏ°Ô °üÂûÇÒ ¼ö ÀÖÀ¸¸ç, »ýü³» À¯ÀüÀÚ¹ßÇöÀÇ ±Ã±ØÀûÀÎ ¾ç»óÀ» ±Ô¸íÇÒ ¼ö ÀÖ°í, ¶ÇÇÑ À¯ÀüÀÚ, ´Ü¹éÁú ¹× Áúº´°£ÀÇ ¿¬°á°í¸®¸¦ Á¦°øÇÑ´Ù. ±âÁ¸ÀÇ biomarker´Â ´Ù¸¥ Áúº´ Ç¥ÁöÀÚ¿Í ¿¬°ü¼ºÀÌ ³ô¾Æ Á÷Á¢ÀûÀÎ À¯Çع°Áú ³ëÃâ À§Çèµµ¸¦ Á¤È®È÷ ÆÇÁ¤ÇÏ±â ¾î·Æ´Ù. µû¶ó¼­ ´ë·®¹ß±¼Å½»ö(high-throughput screen-ing)ÀÌ °¡´ÉÇÑ 2Â÷¿ø Àü±â¿µµ¿ ºÐ¼®°ú MALDI-TOF ¶Ç´Â protein chip array¿Í SELDI-TOF¿¡ ÀÇÇÑ ´Ü¹éÁú ºÐÀÚ±¸Á¶ ºÐ¼®±â¼ú ¹× À̵éÀ» Áö¿øÇÏ´Â »ý¹°Á¤º¸ÇÐ(bio-informatics)ÀÇ ¹ßÀüÀ» ÀÌ¿ëÇÏ¿© ȯ°æµ¶¼º ¿¬±¸¿¡ ÀÌ¿ë ÇÒ ¼ö Àִ ǥÀû´Ü¹éÁú(biomarker)¹ß±¼¿¡ ÀûÀýÇÑ ÀÌ¿ëÀÌ °¡´ÉÇÒ °ÍÀÌ´Ù.
It is important to understand the potential human health implications of exposure to environmental chemicals that may act as hormonally active agents. It is necessary to have an understanding of how pharmaceutical and personal care products and other chemicals affect the ecosystem of our planet as well as human health. Endocrine disruption is defined as the ability of a chemical contaminating the workplace or the environment to interfere with homeostasis, development, reproduction, and/or behavior in a living organism or it's offspring. Certain classes of environmentally persistent chemicals such as polychlorinated biphenyls (PCBs), dioxins, furans, and some pesticides can adversely effect the endocrine systems of aquatic life and terrestrial wildlife. Research continues to support the theory of endocrine disruption. However, endocrine disruption researches have been applied to proteomics poorly. Proteomics can be defined as the systematic analysis of proteins for their identity, quantity and function. It could increase the predictability of early drug development and identify non-invasive biomarkers of tonicity or efficacy. Proteome analysis is most commonly accomplished by the combination of two-dimensional gel electrophoresis (2D/E) and MALDI-TOF mass spectrometry (MS) sr protein chip array and SELDI-TOF MS. Proteomics have an opportunity to play an important role in resolving the question of what role endocrine disruptors play in initiating human disease. Proteomics can also play an imfortant role in the evaluation of the risk assessment and use of risk management and risk communication tools required to address public health concerns related to notions of endocrine disruptors. Understanding the need for the proteomics and possessing knowledge of the developing biomakers used to abbess endocrine activity potential will he essential components relevant to the topic of endocrine disruptors.
 
Ű¿öµå
endocrine disrupting chemicals;proteome;
 
ȯ°æ»ý¹° / v.21, no.2, 2003³â, pp.87-100
Çѱ¹È¯°æ»ý¹°ÇÐȸ
ISSN : 1226-9999
UCI : G100:I100-KOI(KISTI1.1003/JNL.JAKO200311921693881)
¾ð¾î : Çѱ¹¾î
³í¹® Á¦°ø : KISTI Çѱ¹°úÇбâ¼úÁ¤º¸¿¬±¸¿ø
¸ñ·Ïº¸±â
ȸ»ç¼Ò°³ ±¤°í¾È³» ÀÌ¿ë¾à°ü °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ Ã¥ÀÓÀÇ ÇѰè¿Í ¹ýÀû°íÁö À̸ÞÀÏÁÖ¼Ò ¹«´Ü¼öÁý °ÅºÎ °í°´¼¾ÅÍ
   

ÇÏÀ§¹è³ÊÀ̵¿